ViroGates is an international medical technology company headquartered in Denmark and since June 2018 listed on Nasdaq First North Growth Market, Denmark (Ticker code: VIRO).
We aim to be perceived as a trustworthy and open company and will communicate all information correctly, in a balanced, transparent and timely way and simultaneously to investors, equity analysts and other stakeholders in the financial markets to facilitate regular trading and fair pricing of the company’s shares.
Västra Hamnen Corporate Finance
211 19 Malmö
Tel. (+46) 40 200 250